KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Organon (OGN) EBT (2020 - 2025)

Organon (OGN) has 6 years of EBT data on record, last reported at -$148.0 million in Q4 2025.

  • For Q4 2025, EBT fell 214.73% year-over-year to -$148.0 million; the TTM value through Dec 2025 reached $425.0 million, down 47.34%, while the annual FY2025 figure was $425.0 million, 47.34% down from the prior year.
  • EBT reached -$148.0 million in Q4 2025 per OGN's latest filing, down from $243.0 million in the prior quarter.
  • Across five years, EBT topped out at $467.0 million in Q1 2021 and bottomed at -$1.5 billion in Q4 2022.
  • Average EBT over 5 years is $149.2 million, with a median of $235.5 million recorded in 2021.
  • Peak YoY movement for EBT: crashed 719.49% in 2022, then skyrocketed 158.75% in 2024.
  • A 5-year view of EBT shows it stood at $236.0 million in 2021, then crashed by 719.49% to -$1.5 billion in 2022, then skyrocketed by 107.11% to $104.0 million in 2023, then increased by 24.04% to $129.0 million in 2024, then tumbled by 214.73% to -$148.0 million in 2025.
  • Per Business Quant database, its latest 3 readings for EBT were -$148.0 million in Q4 2025, $243.0 million in Q3 2025, and $229.0 million in Q2 2025.